fda compounding semaglutide warning letters november 2025 Congress Introduces SAFE Drugs Act of 2025, Expanding Oversight of Compounded GLP-1 Drugs and Telehealth Providers November 2025 Drug Safety: Recalls

Affordable Access to GLP-1 Obesity Medications: Strategies to Guide Market Action and Policy Solutions

Shown to regulate serotonin and dopamine levels, BPC-157 has also evidenced positive effects in addressing traumatic brain injury and spinal cord compression [8]

(PubMed) DeRitter E, Cohen N, Rubin SH

Taking it on an empty stomach may improve absorption for some

When the medication is stopped, these effects cease and appetite increases again

Side effects Commonly reported side effects of this medication include: Nausea Diarrhea Vomiting Stomach pain Constipation Gastrointestinal issues Bloating Other potential side effects: Indigestion Dizziness Back pain Increased lipase or amylase Altered taste Nasopharyngitis (common cold) Passing gas Bloating Belching Gastroenteritis Decreased appetite Gastroesophageal reflux disease Upset stomach These symptoms often subside as your body adjusts to the medications